A broad spectrum of functional HIV-specific memory B cells in the blood of infected individuals with high CD4+ T-cell counts

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 3, 2011, Pages

  Kunz, Kevin ^a   Reiche, Sven ^a   Dwai, Yamen ^a   Cordes, Christiane ^b   Krznaric, Ivanka ^c   Bussmann, Bianca M ^a,d   Jassoy, Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b PraxisCityOst   (Germany)

^c Practice Dupke/Carganico/Baumgarten   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; TETANUS TOXOID;

ADULT; ANIMAL CELL; CD4 LYMPHOCYTE COUNT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LETTER; MALE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79959720775     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821dd9d1     Document Type: Letter

References (27)

1. Titanji K, Chiodi F, Bellocco R, et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS. 2005;19: 1947-1955. (Pubitemid 41669018)
2. De Milito A, Morch C, Sonnerborg A, et al. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS. 2001;15:957-964. (Pubitemid 32476662)
3. Nagase H, Agematsu K, Kitano K, et al. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol. 2001; 100:250-259.
4. Moir S, Malaspina A, Ogwaro KM, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA. 2001; 98:10362-10367. (Pubitemid 32803025)
5. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983;309:453-458. (Pubitemid 13041485)
6. Malaspina A, Moir S, Orsega SM, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis. 2005;191:1442-1450. (Pubitemid 40563355)
7. Moir S, Ho J, Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205:1797-1805.
8. Titanji K, Velu V, Chennareddi L, et al. Acute depletion of activatedmemory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques. J Clin Invest. 2010;120:3878-3890.
9. Cagigi A, Nilsson A, De Milito A, et al. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design. Vaccine. 2008;26:3016-3025.
10. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9:235-245.
11. Tomaras GD, Haynes BF. HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr Opin HIVAIDS. 2009;4: 373-379.
12. Cheingsong-Popov R, Panagiotidi C, Bowcock S, et al. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ. 1991;302:23-26.
13. Strathdee SA, Frank JW, McLaughlin J, et al. Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS. J Infect Dis. 1995;172:1375-1379.
14. Lange JM, PaulDA,Huisman HG, et al. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed). 1986;293:1459-1462. (Pubitemid 17200394)
15. Lange JM, de Wolf F, Krone WJ, et al. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. AIDS. 1987;1: 155-159. (Pubitemid 18014589)
16. Reiss P, Lange JM, de Ronde A, et al. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. J Med Virol. 1990;30:163-168. (Pubitemid 20146235)
17. Loveday C, Tedder RS. Enzyme-linked immunosorbent assays for the measurement of human immunodeficiency virus, type 1 reverse transcriptase antigen and antibodies. J Virol Methods. 1993;41:181-192.
18. Yoshida T, Mei H, Dorner T, et al. Memory B and memory plasma cells. Immunol Rev. 2010; 237:117-139.
19. Fondere JM, Huguet MF, Macura-Biegun A, et al. Detection and enumeration of circulating HIV-1-specific memory B cells in HIV-1-infected patients. J Acquir Immune Defic Syndr. 2004;35:114-119.
20. Bonsignori M,MoodyMA, Parks RJ, et al. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J Immunol. 2009;183:2708-2717.
21. Bussmann BM, Reiche S, Bieniek B, et al. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. Virology. 2010;397:7-13.
22. Moir S, Buckner CM, Ho J, et al. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood. 2010;116:5571-5579.
23. Pensieroso S, Cagigi A, Palma P, et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA. 2009;106:7939-7944.
24. Guan Y, Sajadi MM, Kamin-Lewis R, et al. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proc Natl Acad Sci USA. 2009;106:3952-3957.
25. Moir S, Buckner CM, Ho J, et al. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood. 2010;116:5571-5579.
26. Binley JM, Klasse PJ, Cao Y, et al. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol. 1997;71:2799-2809. (Pubitemid 27119919)
27. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357: 1903-1915. (Pubitemid 350074686)